Soluble complement complex C5b-9 promotes microglia activation

Journal of Neuroimmunology

Volumn 267, Issue 1-2, 2014, Pages 16-19

  Yang, Chao ^a   Yang, Li ^b   Liu, Yong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Activation; C5b 9; Microglia

Indexed keywords

COMPLEMENT MEMBRANE ATTACK COMPLEX; CYTOKINE;

ADULT; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL MEMBRANE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROGLIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; UPREGULATION;

ACTIVATION; C5B-9; MICROGLIA;

APOPTOSIS; CELL MEMBRANE; CELLS, CULTURED; COMPLEMENT MEMBRANE ATTACK COMPLEX; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC FACTORS; MATRIX METALLOPROTEINASE 2; MICROGLIA; SIGNAL TRANSDUCTION; TEMPORAL LOBE; UP-REGULATION;

EID: 84893694545     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.11.007     Document Type: Article

References (32)

1. Bani-Hani M.G., Greenstein D., Mann B.E., Green C.J., Motterlini R. Modulation of thrombin-induced neuroinflammation in BV-2 microglia by carbon monoxide-releasing molecule 3. J. Pharmacol. Exp. Ther. 2006, 318(3):1315-1322. (Sep).
2. Bologna L., Gotti E., Manganini M., Rambaldi A., Intermesoli T., Introna M., et al. Mechanism of action of type II, glycoengineered, anti-CD20 monoclonal antibody GA101 in B-chronic lymphocytic leukemia whole blood assays in comparison with rituximab and alemtuzumab. J. Immunol. Mar 15 2011, 186(6):3762-3769.
3. Carson M.J., Thrash J.C., Walter B. The cellular response in neuroinflammation: the role of leukocytes, microglia and astrocytes in neuronal death and survival. Clin. Neurosci. Res. 2006, 6(5):237-245. (Dec).
4. Chen Y., Yang C., Jin N., Xie Z., Tang Y., Fei L., et al. Terminal complement complex C5b-9-treated human monocyte-derived dendritic cells undergo maturation and induce Th1 polarization. Eur. J. Immunol. 2007, 37(1):167-176. (Jan).
5. Fosbrink M., Niculescu F., Rus H. The role of c5b-9 terminal complement complex in activation of the cell cycle and transcription. Immunol. Res. 2005, 31(1):37-46.
6. Fosbrink M., Cudrici C., Tegla C.A., Soloviova K., Ito T., Vlaicu S., et al. Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells. Exp. Mol. Pathol. 2009, 86(2):87-94. (Apr).
7. Gao H.M., Zhou H., Zhang F., Wilson B.C., Kam W., Hong J.S. HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration. J. Neurosci. Jan 19 2011, 31(3):1081-1092.
8. Giamarellos-Bourboulis E.J., Bengmark S., Kanellakopoulou K., Kotzampassi K. Pro- and synbiotics to control inflammation and infection in patients with multiple injuries. J. Trauma 2009, 67(4):815-821. (Oct).
9. Giunta B., Obregon D., Velisetty R., Sanberg P.R., Borlongan C.V., Tan J. The immunology of traumatic brain injury: a prime target for Alzheimer's disease prevention. J. Neuroinflammation;9:185 2012.
10. Groeneveld A.B., Tacx A.N., Bossink A.W., van Mierlo G.J., Hack C.E. Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection. Clin. Immunol. 2003, 106(2):106-115. (Feb).
11. Guo R.F., Ward P.A. Mediators and regulation of neutrophil accumulation in inflammatory responses in lung: insights from the IgG immune complex model. Free Radic. Biol. Med. 2002, 33(3):303-310. (Aug 1).
12. Harry G.J. Neuroinflammation: a need to understand microglia as resident cells of the developing brain. Neurotoxicology Jun 2012, 33(3):558-559. (Oct).
13. Harry G.J., Kraft A.D. Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment. Expert Opin. Drug Metab. Toxicol. 2008, 4(10):1265-1277. (Oct).
14. Jaerve A., Muller H.W. Chemokines in CNS injury and repair. Cell Tissue Res. Jul 2012, 349(1):229-248.
15. Kaur C., Rathnasamy G., Ling E.A. Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina. J. Neuroimmune Pharmacol. Mar 2013, 8(1):66-78.
16. Kilgore K.S., Flory C.M., Miller B.F., Evans V.M., Warren J.S. The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells. Am. J. Pathol. 1996, 149(3):953-961. (Sep).
17. Kim B.W., Koppula S., Hong S.S., Jeon S.B., Kwon J.H., Hwang B.Y., et al. Regulation of microglia activity by glaucocalyxin-A: attenuation of lipopolysaccharide-stimulated neuroinflammation through NF-kappaB and p38 MAPK signaling pathways. PLoS One 2013, 8(2):e55792.
18. Kraus S., Fishelson Z. Cell desensitization by sublytic C5b-9 complexes and calcium ionophores depends on activation of protein kinase C. Eur. J. Immunol. 2000, 30(5):1272-1280. (May).
19. Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia Feb 2010, 58(3):253-263.
20. Luo S., Hartmann A., Dahse H.M., Skerka C., Zipfel P.F. Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3. J. Immunol. Aug 15 2010, 185(4):2164-2173.
21. Lyuksutova O.I., Murphey E.D., Toliver-Kinsky T.E., Lin C.Y., Cui W., Williams D.L., et al. Glucan phosphate treatment attenuates burn-induced inflammation and improves resistance to Pseudomonas aeruginosa burn wound infection. Shock 2005, 23(3):224-232. (Mar).
22. Marshall S.A., McClain J.A., Kelso M.L., Hopkins D.M., Pauly J.R., Nixon K. Microglial activation is not equivalent to neuroinflammation in alcohol-induced neurodegeneration: the importance of microglia phenotype. Neurobiol. Dis. Jan 8 2013.
23. Monji A., Kato T.A., Mizoguchi Y., Horikawa H., Seki Y., Kasai M. Neuroinflammation in schizophrenia especially focused on the role of microglia. Prog. Neuropsychopharmacol. Biol. Psychiatry Apr 5 2013, 42:115-121.
24. Nakanishi W., Goto M., Inagaki A., Sekiguchi S., Fujimori K., Okada N. A precise analysis of C5a inhibitory peptide on inflammatory mediators induced after islet transplantation. Transplant. Proc. Nov 2011, 43(9):3235-3238.
25. Qu W.S., Tian D.S., Guo Z.B., Fang J., Zhang Q., Yu Z.Y., et al. Inhibition of EGFR/MAPK 3Q1168 signaling reduces microglial inflammatory response and the associated secondary 317 damage in rats after spinal cord injury. J. Neuroinflammation 2012, 9:178.
26. Rupprecht T.A., Angele B., Klein M., Heesemann J., Pfister H.W., Botto M., et al. Complement C1q and C3 are critical for the innate immune response to Streptococcus pneumoniae in the central nervous system. J. Immunol. 2007, 178(3):1861-1869. (Feb 1).
27. Saadoun S., Waters P., Bell B.A., Vincent A., Verkman A.S., Papadopoulos M.C. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain Feb 2010, 133(Pt 2):349-361.
28. Spolarics Z. The X-files of inflammation: cellular mosaicism of X-linked polymorphic genes and the female advantage in the host response to injury and infection. Shock 2007, 27(6):597-604. (Jun).
29. Sullivan E.V., Zahr N.M. Neuroinflammation as a neurotoxic mechanism in alcoholism: commentary on "increased MCP-1 and microglia in various regions of human alcoholic brain". Exp. Neurol. 2008, 213(1):10-17. (Sep).
30. Wills-Karp M. Complement activation pathways: a bridge between innate and adaptive immune responses in asthma. Proc. Am. Thorac. Soc. 2007, 4(3):247-251. (Jul).
31. Zhou F., Wu J.Y., Sun X.L., Yao H.H., Ding J.H., Hu G. Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation. Neuropsychopharmacology 2007, 32(12):2570-2580. (Dec).
32. Zipfel P.F. Complement and immune defense: from innate immunity to human diseases. Immunol. Lett. 2009, 126(1-2):1-7. (Sep 22).